2005 Annual Meeting | The Neurological Complications of Emerging Infections and Bioterrorism

Date Tuesday 04/12/05

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Joseph R. Berger, MD, FAAN

Topic(s) Global Health and Neuroepidemiology

Learning Objectives Upon completion:
Participants should have a familiarity with a panoply of infectious disorders that often result in neurological disease and that represent a significant potential threat to the world's population; develop a familiarity with the infectious agents, the clinical presentations, the diagnostic measures, and management strategies; and understand the potential for these and other agents to be used in biological warfare.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:45 AM - 07:00 AM		Lessons from the Past - Von Economo's Encephalitis Joseph R. Berger, MD, FAAN
06:45 AM - 08:30 AM		Breakfast
07:00 AM - 07:15 AM		West Nile Virus Kenneth L. Tyler, MD, FAAN
07:15 AM - 07:30 AM		Anthrax Joseph R. Berger, MD, FAAN
07:30 AM - 07:45 AM		Smallpox and the Complications of Vaccination Joseph R. Berger, MD, FAAN
07:45 AM - 08:00 AM		Ebola Virus Kenneth L. Tyler, MD, FAAN
08:00 AM - 08:15 AM		Nippah and Hendra Viruses Kenneth L. Tyler, MD, FAAN
08:15 AM - 08:30 AM		Implications for Bioterrorism

Faculty Disclosures
Joseph R. Berger, MD, FAAN	Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dice Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Assorted .
Kenneth L. Tyler, MD, FAAN	Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities.

��ɫ��

��ɫ��